PerkinElmer expands computing capabilities for biological drug discovery

laboratory interior with microscope digital image portable computer 87646 2503 17805
Through its propriority Signals ™ platform enables Interfaces with Geneious Prime and SnapGene software will help significantly reduce research cycle times and accelerate biologics and vaccine development PerkinElmer, Inc., has announced that its Signals ™ computing platform for documentation, workflow and decision making is expanding to take advantage of existing capabilities in the biological drug discovery area. This breakthrough comes from collaboration with Insightful Science, a software company focused on the global life sciences community. Through this alliance, pharmaceutical and academic research teams can unite the power of the PerkinElmer Signals ™ platform with leading solutions from Insightful Science's bioinformatics division. This includes the popular SnapGene and Geneious...